QPPV.COM KNOWLEDGE ASSESSMENT

EU QPPV Requirements Knowledge Assessment

Test your understanding of the concepts covered by EU QPPV Requirements: Qualification, Location, Authority and Availability.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which evidence would best demonstrate that a QPPV deputy can respond effectively to an urgent regulatory inquiry?

A deputy's unapproved role description with no system access A completed tabletop exercise, documented authority, relevant training and communication logs from an availability drill A list of products marketed by the MAH A vendor invoice showing that the deputy attended a meeting

Question 2 of 10 Which set of records would provide the strongest evidence that the QPPV is integrated into pharmacovigilance governance?

The QPPV's email signature and a general corporate organisation chart A job description, delegation matrix, reporting lines and governance committee minutes showing QPPV participation A list of all employees who have completed general compliance training A vendor invoice and a product marketing plan

Question 3 of 10 Which feature is most important when selecting and empowering a QPPV deputy?

The deputy has a senior job title but no access to safety systems The deputy is authorised, trained, recorded in the delegation log and able to execute high-priority PV processes The deputy is familiar only with administrative meeting arrangements The deputy is selected informally whenever the QPPV takes annual leave

Question 4 of 10 What should the QPPV's relationship to the PSMF be?

The QPPV may remain unaware of its contents if a document specialist owns it The QPPV should understand its content, location and operation and formally accept or sign responsibility as part of governance The QPPV should personally author every section and prohibit contributions from other functions The QPPV only needs access to the PSMF during an inspection

Question 5 of 10 What is the principal purpose of periodic management review of pharmacovigilance performance?

To replace the QPPV's operational oversight To review trends, audit findings, resource needs and decisions, with documented actions, owners and due dates To approve product marketing campaigns To ensure that all PV decisions are made by the finance function

Question 6 of 10 Which statement best describes the relationship between the MAH and the QPPV under the EU pharmacovigilance framework?

The QPPV assumes all legal responsibility for the MAH's pharmacovigilance system The MAH appoints the QPPV and must provide the authority, resources and access needed for the QPPV to fulfil regulatory responsibilities The competent authority appoints the QPPV and the MAH provides administrative support The QPPV is responsible only for individual case safety reports, while the MAH controls the wider system

Question 7 of 10 Which provision is most important for ensuring that a PVA supports effective oversight of an external PV provider?

The vendor's preferred branding and invoice format Defined responsibilities, data flows, reporting timelines, audit rights, training expectations and business continuity arrangements A statement that the vendor may change processes without notification A general commitment to provide services at the lowest cost

Question 8 of 10 Which situation most clearly indicates that an MAH's PSMF is not functioning as an inspection-ready document?

The PSMF links to controlled SOPs and includes review dates The PSMF identifies vendors and the locations where PV activities occur Inspectors cannot rapidly retrieve the current PSMF and its described processes do not match actual operations The PSMF includes a document control page and an index

Question 9 of 10 An MAH has listed a deputy in an internal email but not in its delegation log or PSMF. What weakness does this most directly indicate?

The deputy cannot legally perform any PV task under any circumstances The availability arrangement is not adequately formalised or inspection-demonstrable The MAH must replace the QPPV with the deputy The PSMF is unnecessary when a deputy is appointed

Question 10 of 10 A vendor changes its subcontractor without notifying the MAH, and literature-screening delays result. What is the most appropriate initial response?

Wait for the next annual vendor review before taking action Conduct an impact assessment and root cause analysis, then implement remediation such as backlog reprocessing and CAPA Terminate the QPPV's appointment immediately Delete delayed records to avoid duplicate processing

EU QPPV Requirements Knowledge Assessment

Cookie Settings